Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06298006
Status:
RECRUITING
Last Update Posted:
2024-03-07
First Post:
2024-01-17
Brief Title:
A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients
Sponsor:
Region Örebro County
Organization:
Region Örebro County
Study Overview
Official Title:
Uppföljning av Psykiatriska Kognitiva Och Neurologiska Symtom Hos Post COVID-19 Patienter
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PASC24
Brief Summary:
The prospective longitudinal open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection in a longitudinal manner to see how the disease has affected their physical psychological and cognitive function their ability to be active return to work their health-related quality of life in correlation with potential diagnostic and prognostic markers
Detailed Description:
The aim is to increase knowledge of the underlying biological processes how biomarkers correlate with degree of symptoms mapping their role as diagnostic markers over time 24 months
The investigators follow up to 100 study participants with post-acute sequelae of SARS-CoV-2 infection PASC for 24 months measure their physical psychological and neurocognitive symtoms and how they change over time three visits baseline 12 months 24 months in correlation with biomarkers in blood cerebrospinal fluid and faeces samples as well as neuroradiological changes on MRI baseline 24 months
Knowledge about the late effects of COVID-19 and its pathogenesis is still unknown The findings of the study can therefore be used as a guidance for future actions in healthcare and in the best case can lead to a possible either curative or symptom-relieving treatment
The investigators follow up to 100 study participants with post-acute sequelae of SARS-CoV-2 infection PASC for 24 months measure their physical psychological and neurocognitive symtoms and how they change over time three visits baseline 12 months 24 months in correlation with biomarkers in blood cerebrospinal fluid and faeces samples as well as neuroradiological changes on MRI baseline 24 months
Knowledge about the late effects of COVID-19 and its pathogenesis is still unknown The findings of the study can therefore be used as a guidance for future actions in healthcare and in the best case can lead to a possible either curative or symptom-relieving treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None